Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.
D000293:Adolescent; D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D005260:Female; D006801:Humans; D007470:Monoiodotyrosine; D010911:Pituitary Neoplasms / Q000378:metabolism*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D018492:Dopamine Antagonists; D011388:Prolactin; D007470:Monoiodotyrosine; D004298:Dopamine